Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy By: Philadelphia Business Journal via Business Journals June 03, 2022 at 13:21 PM EDT Trevose-based Lannett Co. provided an update on its ongoing pivotal clinical trial of biosimilar insulin glargine. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
